119-HRES-872 Journalist Public Summary
119 · HRES 872 Supporting the goals and ideals of "Creutzfeldt-Jakob Disease (CJD) Awareness Day".
A bipartisan House resolution introduced November 10, 2025, supports recognizing November 12, 2025, as Creutzfeldt–Jakob Disease (CJD) Awareness Day. It’s symbolic—no new funding or law—but aims to highlight a rare, rapidly fatal brain disease and the value of public-health surveillance. The measure was referred to the House Energy and Commerce Committee; if adopted, it would state the House’s support and raise visibility for patients, families, and researchers.
Headline Summary
A bipartisan House resolution would recognize November 12, 2025, as “Creutzfeldt–Jakob Disease (CJD) Awareness Day,” spotlighting a rare but deadly brain disease and the importance of monitoring it.
What It Does
H. Res. 872 is a simple House resolution that expresses support for the goals and ideals of CJD Awareness Day. It raises awareness of CJD and other prion diseases, underscores the need for surveillance (including postmortem testing), and acknowledges the role of the National Prion Disease Pathology Surveillance Center. It does not change law, appropriate money, or create new programs.
Who’s For It
- Bipartisan House sponsors and co-sponsors: led by Rep. David Valadao, with Reps. Joyce (OH), Fong, Bean (FL), Nadler, Brown, Brownley, Buchanan, Swalwell, Tonko, and Costa listed on introduction.
- Likely supporters include patients, families, and rare-disease/public‑health advocates who want more awareness and strong national surveillance for prion diseases.
Who’s Against It
- No organized opposition identified in the measure’s introduction.
- Potential critiques: awareness resolutions are symbolic and do not fund research, caregiver support, or surveillance capacity.
What’s Next
Status as of November 10, 2025: referred to the House Committee on Energy and Commerce. The committee may take it up for consideration; if the House adopts it (often by voice vote for noncontroversial items), it becomes an official statement of the House’s support. No Senate or presidential action is required.
Discussion